Concepedia

Publication | Open Access

The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes

DOIFull Paper Access

64

Citations

8

References

2012

Year

David A. Fraser, Lien My Diep, Inger Anette Hynås Hovden, Kristian Bernhard Nilsen, Kari Anne Sveen, Ingebjørg Seljeflot, Kristian F. Hanssen
Diabetes Care

Abstract

Our findings suggest that high-dose benfotiamine (300 mg/day) supplementation over 24 months has no significant effects upon peripheral nerve function or soluble markers of inflammation in patients with type 1 diabetes.

References

YearCitations

Page 1